Trans-Ethnic Fine-Mapping of Lipid Loci Identifies Population-Specific Signals and Allelic Heterogeneity That Increases the Trait Variance Explained

Ying Wu(University of North Carolina at Chapel Hill), Lindsay L. Waite(HudsonAlpha Institute for Biotechnology), Anne Jackson(University of Michigan), Wayne Huey‐Herng Sheu(National Yang Ming Chiao Tung University), Steven Buyske(Rutgers, The State University of New Jersey), Devin Absher(HudsonAlpha Institute for Biotechnology), Donna K. Arnett(University of Alabama at Birmingham), Eric Boerwinkle(The University of Texas Health Science Center at Houston), Lori L. Bonnycastle(National Institutes of Health), Cara L. Carty(Fred Hutch Cancer Center), Iona Cheng(University of Hawaiʻi at Mānoa), Barbara Cochran(The University of Texas Health Science Center at Houston), Damien C. Croteau‐Chonka(University of North Carolina at Chapel Hill), Logan Dumitrescu(Vanderbilt University), Charles B. Eaton(Brown University), Nora Franceschini(University of North Carolina at Chapel Hill), Xiuqing Guo(Cedars-Sinai Medical Center), Brian E. Henderson(University of Southern California), Lucia A. Hindorff(National Institutes of Health), Eric H. Kim(Cedars-Sinai Medical Center), Leena Kinnunen(Finnish Institute for Health and Welfare), Pirjo Komulainen(University of Eastern Finland), Wen‐Jane Lee(Taichung Veterans General Hospital), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Yi Lin(Fred Hutch Cancer Center), Jaana Lindström(Finnish Institute for Health and Welfare), Oddgeir Lingaas-Holmen(Norwegian University of Science and Technology), Sabrina L. Mitchell(Vanderbilt University), Narisu Narisu(National Institutes of Health), Jennifer G. Robinson(University of Iowa), Fredrick R. Schumacher(University of Southern California), Alena Stančáková(University of Eastern Finland), Jouko Sundvall(Finnish Institute for Health and Welfare), Yun-Ju Sung(Washington University in St. Louis), Amy J. Swift(National Institutes of Health), Wen‐Chang Wang(National Health Research Institutes), Lynne R. Wilkens(University of Hawaiʻi at Mānoa), Tom Wilsgaard(UiT The Arctic University of Norway), Alicia Young(Fred Hutch Cancer Center), Linda S. Adair(University of North Carolina at Chapel Hill), Christie M. Ballantyne(Baylor College of Medicine), Petra Bůžková(University of Washington), Aravinda Chakravarti(Johns Hopkins University), Francis S. Collins(National Institutes of Health), David Duggan(Translational Genomics Research Institute), Alan B. Feranil(Foundation University), Low-Tone Ho(National Yang Ming Chiao Tung University), Yi‐Jen Hung(Tri-Service General Hospital), Steven C. Hunt(University of Utah), Kristian Hveem(Norwegian University of Science and Technology), Jyh‐Ming Jimmy Juang(National Taiwan University Hospital), Antero Kesäniemi(Oulu University Hospital), Johanna Kuusisto(University of Eastern Finland), Markku Laakso(University of Eastern Finland), Timo A. Lakka(University of Eastern Finland), I‐Te Lee(National Yang Ming Chiao Tung University), Mark Leppert(University of Utah), Tara C. Matise(Rutgers, The State University of New Jersey), Leena Moilanen(Kuopio University Hospital), Inger Njølstad(UiT The Arctic University of Norway), Ulrike Peters(University of Washington), Thomas Quertermous(Stanford University), Rainer Rauramaa(University of Eastern Finland), Jerome I. Rotter(Cedars-Sinai Medical Center), Jouko Saramies(South Karelia Central Hospital), Jaakko Tuomilehto(Universität für Weiterbildung Krems), Matti Uusitupa(University of Eastern Finland), Tzung‐Dau Wang(National Taiwan University Hospital), Michael Boehnke(University of Michigan), Christopher A. Haiman(University of Southern California), Yii‐Der I. Chen(Cedars-Sinai Medical Center), Charles Kooperberg(Fred Hutch Cancer Center), Themistocles L. Assimes(Stanford University), Dana C. Crawford(Vanderbilt University), Chao A. Hsiung(National Health Research Institutes), Kari E. North(University of North Carolina at Chapel Hill), Karen L. Mohlke(University of North Carolina at Chapel Hill)
PLoS Genetics
March 21, 2013
Cited by 122Open Access
Full Text

Abstract

Genome-wide association studies (GWAS) have identified ~100 loci associated with blood lipid levels, but much of the trait heritability remains unexplained, and at most loci the identities of the trait-influencing variants remain unknown. We conducted a trans-ethnic fine-mapping study at 18, 22, and 18 GWAS loci on the Metabochip for their association with triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), respectively, in individuals of African American (n = 6,832), East Asian (n = 9,449), and European (n = 10,829) ancestry. We aimed to identify the variants with strongest association at each locus, identify additional and population-specific signals, refine association signals, and assess the relative significance of previously described functional variants. Among the 58 loci, 33 exhibited evidence of association at P<1 × 10(-4) in at least one ancestry group. Sequential conditional analyses revealed that ten, nine, and four loci in African Americans, Europeans, and East Asians, respectively, exhibited two or more signals. At these loci, accounting for all signals led to a 1.3- to 1.8-fold increase in the explained phenotypic variance compared to the strongest signals. Distinct signals across ancestry groups were identified at PCSK9 and APOA5. Trans-ethnic analyses narrowed the signals to smaller sets of variants at GCKR, PPP1R3B, ABO, LCAT, and ABCA1. Of 27 variants reported previously to have functional effects, 74% exhibited the strongest association at the respective signal. In conclusion, trans-ethnic high-density genotyping and analysis confirm the presence of allelic heterogeneity, allow the identification of population-specific variants, and limit the number of candidate SNPs for functional studies.


Related Papers

No related papers found

Powered by citation graph analysis